The global precision medicine market size is calculated at USD 138.67 billion in 2026 and is predicted to increase from USD 161.55 billion in 2027 to nearly USD 470.53 billion by 2034, growing at a healthy CAGR of 16.50% from 2025 to 2034.
According to Precedence Research, the precision medicine market is on track to reach 470.53 billion dollars by the end of 2034, up from USD 119.03 billion in 2025. The market is growing due to advancements in genomics and biotechnology, enabling personalized treatment tailored to individual patients’ profiles. Increasing demand for targeted therapies and improved clinical outcomes is further driving market growth.
This Report is Readily Available for Immediate Delivery | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1085
Precision Medicine Market
Key Takeaways
🔹 North America dominated the precision
medicine market with a market share of 54% in 2024.
🔹 Asia Pacific is expected to grow at the fastest CAGR between 2025 and 2034.
🔹 By technology, the drug discovery segment held the largest market share in 2024.
🔹 By technology, the bioinformatics segment is registering a healthy CAGR 2025 and 2034.
🔹 By application, the oncology segment dominated the market in 2024.
🔹 By application, the CNS segment is projected to grow at the fastest CAGR 2025 and 2034.
🔹 By product, the consumable segment dominated the market in 2024.
🔹 By product, the instruments segment is expanding at a solid CAGR 2025 and 2034.
🔹 By route of administration, the oral segment led the market.
🔹 By route of administration, the injectables segment is expected to expand at a notable CAGR 2025 and 2034.
🔹 By end-use, the pharmaceutical companies segment held the highest market share in 2024.
🔹 By end-use, the healthcare IT companies segment is growing at the fastest CAGR 2025 and 2034.
What are Precision Medicine?
Precision medicine is an approach to healthcare that uses a person’s genetic makeup, lifestyle, and environment to tailor preventive, diagnostic, and treatment strategies. It aims to deliver more accurate, effective, and personalized medical care compared to traditional one-size-fits-all treatments. The precision medicine market is growing due to rapid advancements in genomics, molecular diagnostics, and data analytics that enable highly personalized treatment approaches.
Rising demand for targeted therapies, especially in cancer and rare diseases, is driving wider adoption. Increased availability of genetic testing, supportive government initiatives, and growing investment from pharmaceutical and biotechnology companies further accelerate the market. Additionally, precision medicine improves treatment effectiveness and reduces adverse effects, making it the preferred approach in modern healthcare.
🔹 According to EFPIA in 2023, precision medicine is increasingly being used for widespread chronic conditions like diabetes, heart disease, cancer, and infections such as COVID-19. By combining genomic data with individual patient health details, it enables more personalized insights, supporting targeted prevention strategies and more effective treatment decisions.
➡️ Become a valued research partner with us ☎ https://www.precedenceresearch.com/schedule-meeting
What are the Core Drivers shaping the Rapid Development of the Precision Medicine Market?
The rapid development of the precision medicine market is driven by breakthroughs in genomics, advanced diagnostics, and AI-driven data analysis that enable highly personalized treatment plans.
The rising prevalence of chronic and genetic diseases, along with growing demand for targeted therapies, is accelerating adoption. Increased investments from pharmaceutical companies, expanding use of biomarkers, and supportive government policies are further strengthening the growth of precision medicine worldwide.
✚ Turn AI disruption into Opportunity. Click to Get the Insights Shaping Tomorrow.
What are the Key trends in the Precision Medicine Market in 2024?
🔹 In January 2024, Apollo Cancer Centre introduced India’s first AI-powered Precision Oncology Centre, highlighting a major advancement in personalized cancer treatment. The center uses artificial intelligence to develop highly tailored care plans for each patient, showcasing the rising role of AI in precision oncology. (Source: https://www.apollohospitals.com)
🔹 In 2024, China advanced its precision medicine efforts by expanding investment in next-generation gene sequencing and large-scale data analytics. The country is also building stronger international collaborations to accelerate progress in personalized healthcare. Source: https://onlinelibrary.wiley.com)
What is the Appearing Challenge in the Precision Medicine Market?
The market faces challenges such as high costs of genetic testing, limited access to advanced diagnostic technologies, and the complexity of integrating large volumes of genomics data. Data privacy concerns, shortage of skilled professionals, and uneven adoption across regions also hinder widespread implementation, slowing the overall growth of precision medicine.
📥 Dive into the Complete Report ➡️ https://www.precedenceresearch.com/precision-medicine-market
Precision Medicine Market Segmental Report Scope
|
Report Attributes |
Key Statistics |
|
Market Size in 2025 |
USD 119.03 Billion |
|
Market Size in 2026 |
USD 138.67 Billion |
|
Market Size by 2034 |
USD 470.53 Billion |
|
CAGR (2025–2034) |
16.50% |
|
Leading Region in 2024 |
North America |
|
Fastest-Growing Market |
Asia Pacific |
|
Base Year |
2024 |
|
Forecast Period |
2025 to 2034 |
|
Segments Covered |
Technology, Application, End User, Sequencing Technology, Product, Route of Administration, Drugs, Region |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Don’t Miss Out! | Instant Access to This Exclusive Report 👉 https://www.precedenceresearch.com/checkout/1085
Case Study: Genomic Profiling Enables 78% Reduction in Tumor Growth in a Stage IV Lung Cancer Patient
In 2024, a 56-year-old male patient in California was diagnosed with Stage IV non-small cell lung cancer (NSCLC). Traditional chemotherapy showed limited progress during the initial treatment phase. His oncologist recommended a precision medicine approach involving comprehensive genomic profiling to identify actionable mutations.
🔍 Step 1: Genomic Sequencing Transforms the Treatment Pathway
Using a next-generation sequencing (NGS) platform,
clinicians detected an EGFR exon 19 deletion—a mutation commonly
associated with high response rates to targeted therapies.
This discovery shifted the treatment plan from generic chemotherapy to a precision-targeted
therapy, significantly improving the patient’s prognosis.
💊 Step 2: Transition to Targeted Therapy (EGFR Inhibitor)
The patient was prescribed an FDA-approved EGFR tyrosine kinase inhibitor, known for its effectiveness in treating EGFR mutation–positive tumors.
Within 12 weeks, imaging results demonstrated:
→ 78% reduction in tumor size
→ Significant improvement in lung function
→ Reduction in therapy-related side effects compared to chemotherapy
→ Improved quality of life and mobility
📈 Step 3: AI-Driven Monitoring Ensures Ongoing Personalization
AI-enabled predictive analytics were used to monitor:
🔹 Response patterns
🔹 Drug tolerance
🔹 Molecular progression risks
This data-driven approach allowed clinicians to make real-time adjustments, keeping the patient on the optimal dosage and proactively preventing adverse events.
🔬 Outcome & Broader Impact
After nine months, the patient achieved partial remission with sustained tumor control and no major toxicity.
This case highlights how precision medicine:
🔹 Identifies the right therapy based on a patient's genetics
🔹 Reduces trial-and-error prescribing
🔹 Improves treatment outcomes with fewer side effects
🔹 Shortens recovery time and increases survival chances
It also demonstrates why oncology leads the precision medicine market and how genomic innovation, AI integration, and targeted drug development are accelerating the industry’s growth toward USD 470.53 billion by 2034.
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Precision Medicine Market Segmental Insights
By Technology Insights
How did the Drug Discovery Segment Dominate the Precision Medicine Market in 2024?
The drug discovery segment held the largest market share in 2024 because precision medicine relies heavily on identifying targeted therapies based on genetic and molecular insights. Advancements in AI genomics and biomarker research accelerated the development of personalized medicine, driving strong demand for innovative discovery platforms. Pharmaceutical companies are increasingly invested in precision-based R&D to improve treatment effectiveness and reduce trial failures, strengthening this segment in the market.
The bioinformatics segment is expected to grow at the fastest CAGR because precision medicine depends on analyzing massive genomic, proteomic, and clinical datasets. Bioinformatics tools enable accurate data interpretation, biomarker identification, and personalized treatment planning. Rising adoption of artificial intelligence and machine learning in healthcare, growing genomic sequencing activities, and increasing demand for data-driven insights are further accelerating the use of bioinformatics, making it a key growth driver in the precision medicine market.
By Application Insights
What made the Oncology Segment Dominant in the Precision Medicine Market in 2024?
The oncology segment dominated the market in 2024 because cancer treatment increasingly relies on genetic profiling and biomarker-based therapies, making precision medicine highly effective in this field. Rising cancer prevalence, demand for targeted drugs, and widespread use of genomic testing strengthened adoption. Advanced diagnostics, personalized treatment plans, and strong investments by pharmaceutical companies further supported oncology’s leading share in the precision medicine market.
The CNS segment is expected to grow at the fastest CAGR because neurological disorders often require highly personalized treatment approaches due to their complex and varied nature. Advances in genomics, biomarker research, and neuroimaging are enabling more precise diagnosis and targeted therapies for conditions like Alzheimer’s, Parkinson’s, and epilepsy. Increasing R&D investment, rising disease prevalence, and growing adoption of data-driven tools are further accelerating precision medicine use in CNS care.
By Product Insights
Why the Consumable Segment Dominated the Precision Medicine Market in 2024?
The consumables segment dominated the market in 2024 because precision medicine relies heavily on continuous use of reagents, kits, assays, and other testing materials for genomic sequencing and molecular diagnostics. Growing demand for frequent testing in oncology, rare diseases, and personalized therapies has increased the need for these products. Their recurring use in research labs, clinical settings, and pharmaceutical R&D further strengthened the segment’s leading position in the market.
The instruments segment is expected to grow at the fastest CAGR because the rising adoption of advanced genomic sequencing, molecular diagnostics, and high-throughput analysis requires sophisticated equipment. Increasing investments in R&D, expanding clinical use of precision medicine, and the need for faster, more accurate testing technologies are driving demand. Continuous innovation in sequencing platforms, imaging tools, and automated laboratory systems further boosts the growth of this segment during the forecast period.
By Route of Administration Insights
Why Did the Oral Segment Dominate the Precision Medicine Market in 2024?
The oral segment led the market because oral therapies are easier to administer, more convenient for patients, and support better treatment adherence compared to injectable or invasive options. Many targeted and precision-based drugs are now formulated as oral medications, making them suitable for long-term use in cancer, rare diseases, and chronic conditions. Their lower administration costs and improved patient comfort further contributed to this segment’s strong market share.
The injectables segment is expected to grow at the fastest CAGR because many precision therapies, especially biologics, monoclonal antibodies, and gene-based treatments, require injection for effective delivery into the bloodstream. These drugs often have complex molecular structures that cannot be taken orally. Rising use of targeted cancer therapies, cell and gene therapy, and long-acting biologics is further increasing demand for injectable administration during the forecast period.
By End-use Insights
How does the Pharmaceutical Companies Segment dominate the Precision Medicine Market in 2024?
The pharmaceutical companies segment held the highest market share in 2024 because these companies are major investors in precision medicine research, drug development, and genomic-based therapies. They rely heavily on advanced molecular profiling, biomarker discovery, and targeted treatment design, driving strong adoption of precision medicine tools. Increasing R&D spending, rising demand for personalized drugs, and the need to reduce trial failures further strengthened pharma’s dominant role in the market.
The healthcare IT companies segment is expected to grow at the fastest CAGR because they provide essential data analytics, bioinformatics, and digital platforms that support precision medicine. Rising demand for integrated healthcare solutions, AI-driven insights, and real-time patient data management is fueling adoption. Increasing collaboration with pharmaceutical and clinical research organizations, along with expanding investment in health IT infrastructure, is accelerating the growth of this segment during the forecast period.
Precision Medicine Market Regional Outlook
What is the U.S. Precision Medicine Market?
The U.S. precision medicine market size is predicted to reach over USD 232.49 billion by 2034, increasing from USD 58.09 billion in 2025 and it is expanding at a double-digit CAGR of 16.66% from 2025 to 2034.
U.S. Precision Medicine Market Key Takeaways
→ By technology, the drug discovery segment held the dominating share of the market in 2024.
→ By application, the oncology segment dominated the U.S. precision medicine market in 2024.
→ By end-use, the pharmaceutical company segment held the largest share of the market in 2024.
→ By sequencing technology, the single molecule real-time sequencing segment is expected to dominate the market over the forecast period.
→ By product, the consumables segment held the largest share of the market in 2024.
→ By route of administration, the oral segment held the largest share of the market in 2024.
→ By drugs, the Mepolizumab segment is observed to witness significant growth during the forecast period.
U.S. Precision Medicine Market Key Players
🔹 NanoString Technologies
🔹 Pfizer
🔹 AbbVie Inc.
🔹 AstraZeneca
🔹 Johnson & Johnson Services, Inc
🔹 Thermo Fisher Scientific, Inc.
🔹 Illumina, Inc.
🔹 ARIEL Precision Medicine, Inc.
Note: This report is readily available for immediate delivery. We can
review it with you in a meeting to ensure data reliability and quality for
decision-making.
📥 Download Sample
Pages for Informed Decision-Making 👉 https://www.precedenceresearch.com/sample/1085
How is North America contributing to the Expansion of the Precision Medicine Market?
North America dominated the market in 2024 due to advanced healthcare infrastructure, widespread adoption of genomic technologies, and significant investments in R&D by pharmaceutical and biotech companies. Supportive government initiatives, strong regulatory frameworks, and high patient awareness of personalized therapies further boosted market growth. The presence of leading precision medicine vendors and extensive clinical trial activities also reinforced the region’s leading revenue share.
🔹 In May 2024, Atara Biotherapeutics submitted a Biologics License Application to the FDA for tabelecleucel (tab-cel), a targeted therapy for EBV+ PTLD in patients aged two and older with prior treatment. This underscores the expanding role of precision medicine in developing personalized treatments for rare and resistant conditions.
How is Asia-Pacific
Accelerating the Precision Medicine Market? Asia Pacific is
anticipated to grow at the fastest CAGR due to increasing healthcare
digitization, expanding hospital infrastructure, and rising investments in
genomics and precision medicine technologies. The growing prevalence of
chronic and genetic diseases, improving access to advanced diagnostics, and
government initiatives supporting personalized healthcare are driving adoption.
Additionally, collaborations with global biotech firms and rising awareness of
targeted therapies are accelerating precision medicine growth in the region. ✚ Related Topics You May
Find Useful: ➡️ Personalized
Medicine Market: Explore how tailored therapies are transforming patient
care and treatment outcomes globally ➡️ Artificial
Intelligence in Precision Medicine Market: Discover how AI is
accelerating drug discovery and enabling data-driven personalized therapies ➡️ Non-Oncology
Precision Medicine Market: Understand growth trends in
personalized treatments beyond cancer, targeting rare and chronic diseases ➡️ Pancreatic
Cancer Precision Medicine Market: Analyze innovations in targeted
therapies for one of the most challenging cancer types ➡️ Precision
Diagnostics Market: Examine how advanced diagnostics are supporting accurate,
personalized treatment decisions ➡️ Personalized
Genomics Market: Gain insights into the role of genomic profiling in shaping
precision healthcare solutions ➡️ Generative AI
in Personalized Medicine Market: Explore how generative AI is
revolutionizing drug design, diagnostics, and patient-specific therapies ➡️ Precision
Oncology Market: Track advancements in targeted cancer therapies and
genomics-guided treatment approaches ➡️ Precision
Genomic Testing Market: Understand the growing adoption of genomic tests for
early disease detection and personalized care ➡️ Regenerative
Medicine Market: Discover emerging therapies that restore, replace, or
regenerate damaged tissues and organs ➡️ Metabolomics Market: Examine how metabolic
profiling is enabling precision diagnostics and therapeutic monitoring Recent Developments in the Precision
Medicine Market 🔹 In March 2025, Illumina partnered with
Cleveland Clinic to create a cloud-based platform aimed at integrating genomic
data into everyday patient care, advancing precision medicine applications. (Source:
https://www.oracle.com) 🔹 In February 2025, Roche gained FDA approval
for a companion diagnostic test to identify patients with NTRK fusion-positive
tumors for treatment with entrectinib, supporting more targeted precision
therapies. (Source: https://www.roche.com) Precision Medicine Market
Top Companies ➢ F. Hoffmann-La Roche
Ltd.-(Foundation Medicine) ➢ Siemens ➢ Janssen Global Services,
LLC ➢ Quest Diagnostics
Incorporated ➢ 23andMe, Inc. ➢ NeoDiagnostix ➢ Myriad Genetics ➢ Medtronic ➢ Abbott ➢ QIAGEN Segment Covered in the
report By Technology 🔹 Bioinformatics 🔹 Big Data Analytics 🔹 Drug Discovery 🔹 Gene Sequencing 🔹 Companion Diagnostics 🔹 Others By Application 🔹 CNS 🔹 Immunology 🔹 Oncology 🔹 Respiratory 🔹 Others By End-Use 🔹 Diagnostic Companies 🔹 Pharmaceutical Companies 🔹 Healthcare IT companies 🔹 Others By Product 🔹 Consumables 🔹 Instruments 🔹 Services By Route of Administration 🔹 Oral 🔹 Injectable By Product 🔹 Standalone 🔹 Integrated By Hospital 🔹 Large Hospital 🔹 Medium Hospital 🔹 Small Hospital By Application 🔹 Cardiology 🔹 Neurology 🔹 Radiology 🔹 Oncology 🔹 Mental and Behavioral
Health 🔹 Nephrology and Urology 🔹 Gastroenterology 🔹 Pediatrics 🔹 General Medicine 🔹 Physical Therapy and
Rehabilitation 🔹 Others By Region 🔹 Europe 🔹 Asia Pacific 🔹Latin America 🔹Middle East & Africa
(MEA) Thanks for reading you can also get
individual chapter-wise sections or region-wise report versions such as North
America, Europe, or Asia Pacific. Don’t Miss Out! | Instant Access to This Exclusive Report 👉 https://www.precedenceresearch.com/checkout/1085 You can place an order or ask any questions, please feel free to contact
at sales@precedenceresearch.com | +1 804 441 9344 Stay Ahead with Precedence Research
Subscriptions Unlock
exclusive access to powerful market intelligence, real-time data, and
forward-looking insights, tailored to your business. From trend tracking to
competitive analysis, our subscription plans keep you informed, agile, and
ahead of the curve. Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription About Us Precedence
Research is a global market intelligence and consulting powerhouse, dedicated
to unlocking deep strategic insights that drive innovation and transformation.
With a laser focus on the dynamic
world of life sciences, we specialize in decoding the complexities
of cell and gene therapy, drug development, and oncology markets, helping our clients stay
ahead in some of the most cutting-edge and high-stakes domains in healthcare.
Our expertise spans across the biotech and pharmaceutical ecosystem, serving
innovators, investors, and institutions that are redefining what’s possible in regenerative medicine, cancer care, precision
therapeutics, and beyond. Web: https://www.precedenceresearch.com ✚ Explore More Market
Intelligence from Precedence Research: ➡️ Digital
Therapeutics: How software-based interventions are restructuring
chronic-disease management and clinical-grade behavioral therapy ➡️ Life
Sciences Growth: Forces driving expansion across biotech, biopharma, and
advanced therapeutic platforms ➡️ Viral
Vector Gene Therapy Manufacturing: Manufacturing constraints,
scalability limits, and innovations shaping next-generation gene-delivery
systems ➡️ Wellness
Transformation: How prevention-centric health models are shifting consumer
behavior, product pipelines, and care delivery ➡️ Generative
AI in Healthcare: How generative models are unlocking new diagnostics, clinical
automation, and patient-care innovations Our Trusted Data Partners: Towards
Healthcare | Nova One
Advisor | Onco Quant | Statifacts Get Recent News 👉 https://www.precedenceresearch.com/news For Latest Update Follow Us:
🔹 North America
